The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer

Petrović, Marina; Bukumirić, Zoran; Zdravković, Vladimir; Mitrović, Slobodanka; Atkinson, Henry; Jurišić, Vladimir
February 2014
Medical Oncology;Feb2014, Vol. 31 Issue 2, p1
Academic Journal
No abstract available.


Related Articles

  • The Prognostic Significance of Circulating Neuroendocrine Markers Chromogranin A, Pro-Gastrin-Releasing Peptide and Neuron-Specific Enolase in Patients with Advanced Non-Small-Cell Lung Cancer. Nisman, Benjamin; Heching, Norman; Biran, Haim; Barak, Vivian; Peretz, Tamar // Tumor Biology;2006, Vol. 27 Issue 1, p8 

    Background: Chromogranin A (CGA), Pro-gastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) are known as immunohistochemical tissue markers closely associated with neuroendocrine differentiation in non-small-cell lung carcinoma (NSCLC). The aim of the present study was to assess...

  • Prognostic importance of neuroendocrine differentiation in Japanese breast cancer patients. Sawaki, Masataka; Yokoi, Kazuki; Nagasaka, Tetsuro; Watanabe, Reiko; Kagawa, Chikara; Takada, Hideki; Sato, Shigenori; Yamada, Tomohiro; Kikumori, Toyone; Imai, Tsuneo; Nakao, Akimasa // Surgery Today;Sep2010, Vol. 40 Issue 9, p831 

    Purpose: To evaluate the frequency and prognostic importance of neuroendocrine differentiation (NED) in Japanese breast cancer patients. Methods: We used standard immunohistochemical techniques to examine 50 patients who underwent resection of breast cancer between 1988 and 1993 at the...

  • An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival. Korse, C. M.; Taal, B. G.; Bonfrer, J. M. G.; Vincent, A.; van Velthuysen, M. L.; Baas, P. // Annals of Oncology;Dec2011, Vol. 22 Issue 12, p2625 

    Background: Progastrin-releasing peptide (proGRP) is a recently identified biomarker of small-cell lung cancer. In well-differentiated neuroendocrine tumours (WDNETs), this study investigates the association between proGRP and tumour characteristics and the prognostic value of proGRP levels...

  • Serum Pro-Gastrin-Releasing Peptide Is a Useful Marker for Treatment Monitoring and Survival in Small-Cell Lung Cancer. Sunaga, Noriaki; Tsuchiya, Satoshi; Minato, Koichi; Watanabe, Satoru; Fueki, Naoto; Hoshino, Hideki; Makimoto, Takeyuki; Ishihara, Shinichi; Saito, Ryusei; Mori, Masatomo // Oncology;1999, Vol. 57 Issue 2, p143 

    We investigated the usefulness of serum pro-gastrin-releasing peptide (Pro-GRP) as a tumor marker for diagnosis, treatment monitoring and the prediction of relapse and prognosis in patients with small-cell lung cancer (SCLC). Serum samples were obtained from 127 patients with primary lung cancer...

  • Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients. Stovold, R; Meredith, S L; Bryant, J L; Babur, M; Williams, K J; Dean, E J; Dive, C; Blackhall, F H; White, A // British Journal of Cancer;4/30/2013, Vol. 108 Issue 8, p1704 

    Background:Small-cell lung cancer (SCLC) has a very aggressive clinical course with early metastasis. This study investigated how the distinctive neuroendocrine characteristics contribute to disease progression and invasion in human SCLC.Methods:The neuroendocrine phenotype (pro-opiomelanocortin...

  • hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Jiang, Shi-Xu; Kameya, Toru; Asamura, Hisao; Umezawa, Atsuko; Sato, Yuichi; Shinada, Jun; Kawakubo, Yasuaki; Igarashi, Toru; Nagai, Kanji; Okayasu, Isao // Modern Pathology;Feb2004, Vol. 17 Issue 2, p222 

    The human homolog 1 of the Drosophila neurogenic achaete-scute genes, hASH1, is specifically expressed in fetal pulmonary neuroendocrine cells and in some neuroendocrine tumor cell lines. However, no data have been gathered regarding its in vivo expression in tumors. hASH1 mRNA expression was...

  • Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer. Molina, Rafael; Marrades, Ramon M.; Auge, Josep Maria; Escudero, Jose M.; Viñolas, Nuria; Reguart, Noemi; Ramirez, Jose; Filella, Xavier; Molins, Laureano; Agustí, Alvar; Augé, Josep Maria // American Journal of Respiratory & Critical Care Medicine;2/15/2016, Vol. 193 Issue 4, p427 

    Rationale: We have previously identified six serum tumor markers (TMs) (carcinoembryonic antigen, carbohydrate antigen 15.3, squamous cell carcinoma-associated antigen, cytokeratin-19 fragment, neuron-specific enolase, and pro-gastrin-releasing peptide) related to the presence of...

  • High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin. Tacke, Frank; Galm, Oliver; Kanig, Nicolas; Yagmur, Eray; Brandt, Sabine; Lindquist, Jonathan A.; Eberhardt, Christiane S.; Raffetseder, Ute; Mertens, Peter R. // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background Expression of the cold shock protein Y-box protein 1 (YB-1) is associated with deleterious outcome in various malignant diseases. Our group recently showed that the detection of an 18 kDa YB-1 fragment (YB-1/p18) in human plasma identifies patients with malignant diseases. We now...

  • Immunohistochemical Reactions of Primary Neuroendocrine Breast Cancer. Kirillina, M.; Loskutova, K.; Innokent'eva, A.; Lushnikova, E.; Nepomnyashchikh, L. // Bulletin of Experimental Biology & Medicine;Jan2015, Vol. 158 Issue 3, p368 

    We performed immunohistochemical analysis of neuroendocrine breast cancer. The significance of this approach to differential diagnosis of this cancer form by detection of specific markers is demonstrated. The incidence of diagnosis of neuroendocrine breast cancer has increased 8-fold over 5...

  • Histidine Decarboxylase Expression as a New Sensitive and Specific Marker for Small Cell Lung Carcinoma. Matsuki, Yasumasa; Tanimoto, Akihide; Hamada, Tetsuo; Sasaguri, Yasuyuki // Modern Pathology;Jan2003, Vol. 16 Issue 1, p72 

    Histidine decarboxylase is one of the enzymes of the amine precursor uptake and decarboxylation system and is known to be distributed in mast cells and enterochromaffin-like cells. With the hypothesis that histidine decarboxylase expression is a marker for neuroendocrine differentiation, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics